Sponsored Links
| Spartan Bioscience Announces CE Marking For First Point-of-Care DNA Personalized Medicine Testing System |
 |
 |
 |
| Medical News - Heart Disease | |||
|
Spartan Bioscience Inc., a privately held molecular diagnostics company that develops, manufactures, and markets DNA testing systems for on-demand applications, announced its Spartan RX CYP2C19 received a CE IVD Mark under the European Directive on In Vitro Diagnostic Medical Devices... Read more: Heart Disease News From Medical News Today
|